Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fluid Biomarkers for Synaptic Dysfunction and Loss
Elena Camporesi, Johanna Nilsson, Ann Brinkmalm, et al.
Biomarker Insights (2020) Vol. 15, pp. 117727192095031-117727192095031
Open Access | Times Cited: 107

Showing 1-25 of 107 citing articles:

Blood-based biomarkers for Alzheimer's disease: towards clinical implementation
Charlotte E. Teunissen, Inge M.W. Verberk, Elisabeth H. Thijssen, et al.
The Lancet Neurology (2021) Vol. 21, Iss. 1, pp. 66-77
Open Access | Times Cited: 354
Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies
Priyanka Rawat, Ujala Sehar, Jasbir Bisht, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12841-12841
Open Access | Times Cited: 184
Omics sciences for systems biology in Alzheimer’s disease: State-of-the-art of the evidence
Harald Hampel, Robert Nisticò, Nicholas T. Seyfried, et al.
Ageing Research Reviews (2021) Vol. 69, pp. 101346-101346
Closed Access | Times Cited: 107
Tau Oligomer–Containing Synapse Elimination by Microglia and Astrocytes in Alzheimer Disease
Raquel N. Taddei, Romain Perbet, Anastasie Maté de Gérando, et al.
JAMA Neurology (2023) Vol. 80, Iss. 11, pp. 1209-1209
Open Access | Times Cited: 47
Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer’s disease
Nicolai Franzmeier, Amir Dehsarvi, Anna Steward, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 21
Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases
Johanna Nilsson, Alexa Pichet Binette, Sebastian Palmqvist, et al.
Brain (2024) Vol. 147, Iss. 7, pp. 2414-2427
Open Access | Times Cited: 21
Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease
Johanna Nilsson, Johan Gobom, Simon Sjödin, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 59
Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration
Nerea Gómez de San José, Federico Massa, Steffen Halbgebauer, et al.
Journal of Neural Transmission (2021) Vol. 129, Iss. 2, pp. 207-230
Open Access | Times Cited: 57
Increased levels of the synaptic proteins PSD-95, SNAP-25, and neurogranin in the cerebrospinal fluid of patients with Alzheimer’s disease
Pia Kivisäkk, Becky C. Carlyle, Thadryan Sweeney, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 47
Biofluid‐based biomarkers for Alzheimer's disease–related pathologies: An update and synthesis of the literature
Henrik Zetterberg
Alzheimer s & Dementia (2022) Vol. 18, Iss. 9, pp. 1687-1693
Open Access | Times Cited: 44
Cerebrospinal fluid biomarker panel of synaptic dysfunction in Alzheimer's disease and other neurodegenerative disorders
Johanna Nilsson, Katheryn A Q Cousins, Johan Gobom, et al.
Alzheimer s & Dementia (2022) Vol. 19, Iss. 5, pp. 1775-1784
Open Access | Times Cited: 38
Integrative metabolomics science in Alzheimer’s disease: Relevance and future perspectives
Simone Lista, Raúl González‐Domínguez, Susana López‐Ortiz, et al.
Ageing Research Reviews (2023) Vol. 89, pp. 101987-101987
Closed Access | Times Cited: 33
Detecting Early Cognitive Decline in Alzheimer’s Disease with Brain Synaptic Structural and Functional Evaluation
Samo Ribarič
Biomedicines (2023) Vol. 11, Iss. 2, pp. 355-355
Open Access | Times Cited: 23
NPTX2 in Cerebrospinal Fluid Predicts the Progression From Normal Cognition to Mild Cognitive Impairment
Anja Soldan, Sungtaek Oh, Taekyung Ryu, et al.
Annals of Neurology (2023) Vol. 94, Iss. 4, pp. 620-631
Open Access | Times Cited: 23
Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers
Lucy L. Gibson, Carla Abdelnour, Joyce R. Chong, et al.
Current Opinion in Neurology (2023)
Open Access | Times Cited: 23
Delivering synaptic protein mRNAs via extracellular vesicles ameliorates cognitive impairment in a mouse model of Alzheimer’s disease
Huimin Cai, Yana Pang, Ziye Ren, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Synapse vulnerability and resilience underlying Alzheimer’s disease
Raquel N. Taddei, Karen Duff
EBioMedicine (2025) Vol. 112, pp. 105557-105557
Open Access | Times Cited: 1
Sources and triggers of oxidative damage in neurodegeneration
Plamena R. Angelova
Free Radical Biology and Medicine (2021) Vol. 173, pp. 52-63
Open Access | Times Cited: 47
Biomarkers for Alzheimer’s Disease: Context of Use, Qualification, and Roadmap for Clinical Implementation
Jeffrey L. Cummings, Jefferson W. Kinney
Medicina (2022) Vol. 58, Iss. 7, pp. 952-952
Open Access | Times Cited: 33
Advances in single molecule arrays (SIMOA) for ultra-sensitive detection of biomolecules
Renkai Dong, Yi Ning, Dechen Jiang
Talanta (2023) Vol. 270, pp. 125529-125529
Closed Access | Times Cited: 16
The glutamatergic system in Alzheimer’s disease: a systematic review with meta-analysis
Carolina Soares, Lucas Uglione Da Ros, Luiza Santos Machado, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 7, pp. 2261-2273
Closed Access | Times Cited: 7
Emerging perspectives of synaptic biomarkers in ALS and FTD
Karrthik Krishnamurthy, Raj Kumar Pradhan
Frontiers in Molecular Neuroscience (2024) Vol. 16
Open Access | Times Cited: 6
Cerebrospinal fluid shotgun proteomics identifies distinct proteomic patterns in cerebral amyloid angiopathy rodent models and human patients
Marc Vervuurt, Joseph M. Schrader, Anna M. de Kort, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 6
Hippocampal Lactate-Infusion Enhances Spatial Memory Correlated with Monocarboxylate Transporter 2 and Lactylation
Yuhan Wu, Hui Hu, Weiwei Liu, et al.
Brain Sciences (2024) Vol. 14, Iss. 4, pp. 327-327
Open Access | Times Cited: 6
Lysosomal and synaptic dysfunction markers in longitudinal cerebrospinal fluid of de novo Parkinson’s disease
Michael Bartl, Johanna Nilsson, Mohammed Dakna, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top